The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global NK Cell Therapy Market Research Report 2024
Synopsis
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The global NK Cell Therapy market was valued at US$ 347.8 million in 2023 and is anticipated to reach US$ 1006.7 million by 2030, witnessing a CAGR of 16.2% during the forecast period 2024-2030.
North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. Top 3 companies occupied about 82% market share.
This report aims to provide a comprehensive presentation of the global market for NK Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK Cell Therapy.
Report Scope
The NK Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NK Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NK Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application
Cancer
Gastrointestinal Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NK Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The global NK Cell Therapy market was valued at US$ 347.8 million in 2023 and is anticipated to reach US$ 1006.7 million by 2030, witnessing a CAGR of 16.2% during the forecast period 2024-2030.
North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. Top 3 companies occupied about 82% market share.
This report aims to provide a comprehensive presentation of the global market for NK Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK Cell Therapy.
Report Scope
The NK Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NK Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NK Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application
Cancer
Gastrointestinal Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NK Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global NK Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NK Cell Therapy Market Perspective (2019-2030)
2.2 NK Cell Therapy Growth Trends by Region
2.2.1 Global NK Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 NK Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 NK Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 NK Cell Therapy Market Dynamics
2.3.1 NK Cell Therapy Industry Trends
2.3.2 NK Cell Therapy Market Drivers
2.3.3 NK Cell Therapy Market Challenges
2.3.4 NK Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NK Cell Therapy Players by Revenue
3.1.1 Global Top NK Cell Therapy Players by Revenue (2019-2024)
3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NK Cell Therapy Revenue
3.4 Global NK Cell Therapy Market Concentration Ratio
3.4.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2023
3.5 NK Cell Therapy Key Players Head office and Area Served
3.6 Key Players NK Cell Therapy Product Solution and Service
3.7 Date of Enter into NK Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NK Cell Therapy Breakdown Data by Type
4.1 Global NK Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global NK Cell Therapy Forecasted Market Size by Type (2025-2030)
5 NK Cell Therapy Breakdown Data by Application
5.1 Global NK Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global NK Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America NK Cell Therapy Market Size (2019-2030)
6.2 North America NK Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America NK Cell Therapy Market Size by Country (2019-2024)
6.4 North America NK Cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NK Cell Therapy Market Size (2019-2030)
7.2 Europe NK Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe NK Cell Therapy Market Size by Country (2019-2024)
7.4 Europe NK Cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NK Cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific NK Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific NK Cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific NK Cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NK Cell Therapy Market Size (2019-2030)
9.2 Latin America NK Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America NK Cell Therapy Market Size by Country (2019-2024)
9.4 Latin America NK Cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NK Cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa NK Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa NK Cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa NK Cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Detail
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics NK Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2019-2024)
11.1.5 Nektar Therapeutics Recent Development
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Detail
11.2.2 Innate Pharma SA Business Overview
11.2.3 Innate Pharma SA NK Cell Therapy Introduction
11.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2019-2024)
11.2.5 Innate Pharma SA Recent Development
11.3 Affimed
11.3.1 Affimed Company Detail
11.3.2 Affimed Business Overview
11.3.3 Affimed NK Cell Therapy Introduction
11.3.4 Affimed Revenue in NK Cell Therapy Business (2019-2024)
11.3.5 Affimed Recent Development
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Detail
11.4.2 Chipscreen Biosciences Business Overview
11.4.3 Chipscreen Biosciences NK Cell Therapy Introduction
11.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2019-2024)
11.4.5 Chipscreen Biosciences Recent Development
11.5 Fate Therapeutics
11.5.1 Fate Therapeutics Company Detail
11.5.2 Fate Therapeutics Business Overview
11.5.3 Fate Therapeutics NK Cell Therapy Introduction
11.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2019-2024)
11.5.5 Fate Therapeutics Recent Development
11.6 Glycostem Therapeutics
11.6.1 Glycostem Therapeutics Company Detail
11.6.2 Glycostem Therapeutics Business Overview
11.6.3 Glycostem Therapeutics NK Cell Therapy Introduction
11.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2019-2024)
11.6.5 Glycostem Therapeutics Recent Development
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Detail
11.7.2 Dragonfly Therapeutics Business Overview
11.7.3 Dragonfly Therapeutics NK Cell Therapy Introduction
11.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2019-2024)
11.7.5 Dragonfly Therapeutics Recent Development
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Detail
11.8.2 Kiadis Pharma Business Overview
11.8.3 Kiadis Pharma NK Cell Therapy Introduction
11.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2019-2024)
11.8.5 Kiadis Pharma Recent Development
11.9 NantWorks
11.9.1 NantWorks Company Detail
11.9.2 NantWorks Business Overview
11.9.3 NantWorks NK Cell Therapy Introduction
11.9.4 NantWorks Revenue in NK Cell Therapy Business (2019-2024)
11.9.5 NantWorks Recent Development
11.10 Nkarta Therapeutics
11.10.1 Nkarta Therapeutics Company Detail
11.10.2 Nkarta Therapeutics Business Overview
11.10.3 Nkarta Therapeutics NK Cell Therapy Introduction
11.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2019-2024)
11.10.5 Nkarta Therapeutics Recent Development
11.11 Fortress Biotech
11.11.1 Fortress Biotech Company Detail
11.11.2 Fortress Biotech Business Overview
11.11.3 Fortress Biotech NK Cell Therapy Introduction
11.11.4 Fortress Biotech Revenue in NK Cell Therapy Business (2019-2024)
11.11.5 Fortress Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
